EXHIBIT 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Dermata Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
| Security Type |
| Security Class Title |
| Fee Calculation or Carry Forward Rule |
| Amount Registered (1) |
| Proposed Maximum Offering Price Per Unit (2) |
|
Maximum Aggregate Offering Price (1) |
| Fee Rate |
|
| Amount of Registration Fee |
| |||||
| Fees to Be Paid |
| Equity |
| Common Stock, par value $0.0001 per share |
| Rule 457(c) |
|
| 856,938 |
| $ | 1.645 |
| $ | 1,409,663 |
| $ | 0.00011020 |
|
| $ | 155.34 |
|
|
|
|
| Total Offering Amounts |
|
|
|
|
|
|
|
|
|
|
|
|
|
| $ | 155.34 |
| |||
|
|
|
| Total Fees Previously Paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
| $ | 0 |
| |||
|
|
|
| Net Fee Due |
|
|
|
|
|
|
|
|
|
|
|
|
|
| $ | 155.34 |
| |||
| (1) | Pursuant to Rule 416 under the Securities Act, there is also being registered hereby such indeterminate number of additional common shares as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $1.645, the average of the high $1.68 and low $1.61 reported sales prices of the registrant’s common stock on the Nasdaq Capital Market on July 6, 2023. |